<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (IL) are the most frequent <z:mp ids='MP_0002022'>lymphoid tumors</z:mp> encountered in human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV)-infected patients </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> with a <z:mp ids='MP_0000002'>morphology</z:mp> intermediate between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and IL, and the existence of Burkitt's type translocations in some IL cases makes the classification of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> sometimes unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We have studied 14 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and IL in HIV-seropositive individuals with regard to clonality, Epstein-Barr virus (EBV) association, and the presence of c-myc rearrangement </plain></SENT>
<SENT sid="3" pm="."><plain>Of seven <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with <z:mp ids='MP_0000002'>morphology</z:mp> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, <z:hpo ids='HP_0000001'>all</z:hpo> were monoclonal, six showed a c-myc rearrangement and four were associated with EBV </plain></SENT>
<SENT sid="4" pm="."><plain>Five <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with <z:mp ids='MP_0000002'>morphology</z:mp> of IL were associated with EBV and devoid of c-myc rearrangement </plain></SENT>
<SENT sid="5" pm="."><plain>Three were polyclonal representing EBV-driven lymphoproliferations similar to those observed in transplant recipients </plain></SENT>
<SENT sid="6" pm="."><plain>Two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, one with a <z:mp ids='MP_0000002'>morphology</z:mp> of IL and the other intermediate between IL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> were monoclonal, associated with EBV, and harbored a c-myc rearrangement </plain></SENT>
<SENT sid="7" pm="."><plain>We propose that these last two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> represent cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> that have adopted an <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> morphotype in the context of acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>), reflecting the morphologic evolution of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells observed in culture </plain></SENT>
</text></document>